Graham Capital Management’s RxSight RXST Stock Holding History

Graham Capital Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$163K	Buy	26,428 +1,328	+5%	+$11K	﹤0.01%	984
2025 Q4	$262K	Buy	+25,100	New	+$252K	0.01%	925
2025 Q2	–	Sell	-28,403	Closed	-$717K	–	1575
2025 Q1	$717K	Buy	+28,403	New	+$844K	0.01%	659
2024 Q4	–	Sell	-15,985	Closed	-$790K	–	1451
2024 Q3	$790K	Buy	15,985 +4,654	+41%	+$238K	0.01%	523
2024 Q2	$682K	Buy	+11,331	New	+$648K	0.01%	492
2023 Q3	–	Sell	-10,012	Closed	-$288K	–	1255
2023 Q2	$288K	Buy	+10,012	New	+$223K	0.01%	701

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Graham Capital Management's RXST Position: Q1 2026 in Review

Graham Capital Management increased its RxSight (RXST) stake by 5.3% in Q1 2026, buying an estimated $11K and bringing the position to 26,428 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #984.

Graham Capital Management first reported a position in RXST in Q2 2023 and has held it in 6 quarters since. The position peaked at $790K in Q3 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Graham Capital Management held 26,428 shares of RxSight worth $163K as of Q1 2026.
Graham Capital Management bought 1,328 RxSight shares in Q1 2026, an estimated $11K.
RxSight made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #984 holding.
Graham Capital Management first reported a position in RxSight in Q2 2023 and has held it in 6 quarters since.
Graham Capital Management's RxSight position peaked at $790K in Q3 2024.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.